
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience
Eye stem cell treatment itself is usually a single, minimally invasive procedure — but what happens before and after it often matters just as much for long-term outcomes. For patients considering treatment for conditions like retinitis pigmentosa, optic atrophy, or Stargardt’s disease, understanding the full journey — not just the day of the procedure — helps set realistic expectations. Here’s what that journey typically looks like.
For most patients, the process begins long before any travel. Medical reports — including recent eye examinations, OCT scans, and relevant diagnostic history — are reviewed remotely by our specialists. A Stem Cell Biotechnology Specialist assesses whether the proposed treatment plan is appropriate for your specific eye condition, while a General Physician separately reviews your overall health status. This step exists specifically to give patients an honest opinion, including if treatment is unlikely to help, before any travel commitment is made.
Once a patient travels for treatment, the first part of the visit typically involves a detailed in-person eye examination to confirm the remote assessment, review any changes since the initial reports were shared, and finalise the treatment plan. This is also when patients can ask questions directly, discuss realistic expectations for their specific condition and disease stage, and understand exactly what the procedure will involve.
The procedure itself is generally brief and performed under appropriate medical supervision. Because eye stem cell treatment is minimally invasive, most patients do not require extended hospitalisation. The specifics of the procedure — including cell delivery method and any sedation used — are discussed with the patient beforehand, so there are no surprises on the day itself.
The first few days after treatment typically involve rest, monitoring for any signs of irritation or complication, and a follow-up eye examination before the patient is cleared to travel home. This is also when patients receive guidance on what changes to expect in the coming weeks, what is not expected to change, and what symptoms — if any — should prompt contact with the clinic.
Recovery and any potential improvement from stem cell treatment generally unfold gradually, not immediately. Follow-up is coordinated with the patient’s local ophthalmologist where possible, along with periodic remote check-ins from our team. Patients are encouraged to maintain realistic timelines — regenerative treatment outcomes vary by condition, disease stage, and individual biology, and responsible providers will be upfront about this rather than promising a fixed result or timeline.
– What does my specific diagnosis and disease stage mean for the likely benefit of treatment?
– What will the pre-treatment assessment involve on arrival, and how long does the full visit typically take?
– What symptoms after treatment would warrant contacting the clinic directly?
– How is follow-up coordinated with my eye doctor back home?
For most international patients, the full journey — from initial remote review to in-person evaluation, treatment, and short-term monitoring — takes roughly 7 to 14 days on the ground in India, with longer-term follow-up then coordinated remotely. This structure is designed to allow for proper medical evaluation at every stage while minimising time away from work and family.
Stem Cell Therapy for Eye Disease in India

